Article Text

Download PDFPDF

Review
Outcomes from stereotactic surgery for essential tremor
  1. Robert Francis Dallapiazza1,
  2. Darrin J Lee1,
  3. Philippe De Vloo1,
  4. Anton Fomenko1,
  5. Clement Hamani1,
  6. Mojgan Hodaie1,
  7. Suneil K Kalia1,
  8. Alfonso Fasano2,3,4,
  9. Andres M Lozano1
  1. 1 Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
  2. 2 Edmond J. Safra Program in Parkinson’s Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada
  3. 3 Division of Neurology, University of Toronto, Toronto, Ontario, Canada
  4. 4 Krembil Research Institute, Toronto, Ontario, Canada
  1. Correspondence to Dr Robert Francis Dallapiazza, Division of Neurosurgery, Toronto Western Hospital, Toronto, ON M5T 2S8, Canada; rfdallapiazza{at}gmail.com

Abstract

There are several different surgical procedures that are used to treat essential tremor (ET), including deep brain stimulation (DBS) and thalamotomy procedures with radiofrequency (RF), radiosurgery (RS) and most recently, focused ultrasound (FUS). Choosing a surgical treatment requires a careful presentation and discussion of the benefits and drawbacks of each. We conducted a literature review to compare the attributes and make an appraisal of these various procedures. DBS was the most commonly reported treatment for ET. One-year tremor reductions ranged from 53% to 63% with unilateral Vim DBS. Similar improvements were demonstrated with RF (range, 74%–90%), RS (range, 48%–63%) and FUS thalamotomy (range, 35%–75%). Overall, bilateral Vim DBS demonstrated more improvement in tremor reduction since both upper extremities were treated (range, 66%–78%). Several studies show continued beneficial effects from DBS up to five years. Long-term follow-up data also support RF and gamma knife radiosurgical thalamotomy treatments. Quality of life measures were similarly improved among patients who received all treatments. Paraesthesias, dysarthria and ataxia were commonly reported adverse effects in all treatment modalities and were more common with bilateral DBS surgery. Many of the neurological complications were transient and resolved after surgery. DBS surgery had the added benefit of programming adjustments to minimise stimulation-related complications. Permanent neurological complications were most commonly reported for RF thalamotomy. Thalamic DBS is an effective, safe treatment with a long history. For patients who are medically unfit or reluctant to undergo DBS, several thalamic lesioning methods have parallel benefits to unilateral DBS surgery. Each of these surgical modalities has its own nuance for treatment and patient selection. These factors should be carefully considered by both neurosurgeons and patients when selecting an appropriate treatment for ET.

  • stereotaxic surgery
  • tremor
  • ultrasound
  • electrical stimulation

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors RFD: Research project: conception, organisation, execution; Manuscript: writing of the first draft, review and critique. DJL, PVD, AFa: Research project: execution; Manuscript: review and critique. CH, MH, SKK, AFo: Research project: organisation; Manuscript: review and critique. AML: Research project: conception, execution; Manuscript: review and critique.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests PDV has received grants for research from Research Fund Flanders (FWO) and the European Society for Stereotactic and Functional Neurosurgery (ESSFN) and grants for education and travel from the World Society of Stereotactic and Functional Neurosurgery (WSSFN), Medtronic and St. Jude-Abbott. AML is a consultant for Medtronic, Boston Scientific and Insightech. Alfonso Fasano is a consultant for Abbvie, Medtronic, Boston Scientific, Sunovion, Chiesi farmaceutici, UCB, Ipsen.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.